Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

Anti-TB Drugs and formulations

  1. Home
  2. Anti-TB Drugs and formulations
  3. Anti-TB Drugs and formulations

Node Status

  • Live
Learning Objectives

Describe

  1. The various Anti TB Drugs that are in use in NTEP
  2. The various types of formulations (single drug and FDC and simple tablet, dispersible and inejctions)

Sub Nodes

  • Discovery of Anti TB Drugs
  • Pharmacological Basis of treatment
  • First line anti TB drugs
  • Fixed Dose Combinations [FDC]s
  • Second Line anti TB drugs
  • Newer Anti-TB Drugs
  • Rationale for Grouping of Anti-TB Drugs
  • Drugs Not Included in Groups A - C and Rationale for Non-inclusion​
  • Role of the State Drug Store [SDS] in the Constitution of Patient-wise Boxes
  • Reconstitution of drugs like second line, newer, TPT etc
  • Quality Assurance of Anti-TB Drugs
  • Patient-wise Boxes [PWB]
  • Pharmacovigilance in NTEP
Linked Nodes
Management of TB Disease

KM Node Tags

  • Procurement and supply chain management

Linked Content Page

No content linked currently.
Add Content Page


User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International